Share

MYOCET® PROTOCOL (PHASE II) 

Project objectives

Use of non-pegylated liposomal Doxorubicin (Myocet®) as second line in advanced epithelial ovarian cancer. 

Start and end date
2007 - 2011

Project Manager
Prof. Angioli Roberto - Coordinator

Coordinating institution of the project
UCBM
2023© Università Campus Bio-Medico di Roma, Via Álvaro del Portillo, 21 - 00128 Rome, Tel. +39 06.22541.1, Fax +39 06.22541.456, VAT number: 048 020 51 005, Fiscal Code: 97087620585
QUICK LINKS
L'Università Campus Bio-Medico di Roma promotes integrated teaching and research structures, pursuing the good of the person as the main aim of its activities.
magnifiercrossmenuchevron-downchevron-leftchevron-right